Nanotechnology’s growing functions within the medical subject are creating a chance for traders to take part on this rising market, based on David Regan, CEO of Sona Nanotech (CSE:SONA,OTCQB:SNANF), a life science firm primarily based in Halifax, Nova Scotia.
“This innovation is the place development occurs,” stated Regan. “There’s been a ton of analysis that has gone into each the manipulation of nanotechnology and quite a lot of work on immunotherapies for most cancers sufferers.”
Sona Nanotech is creating its Focused Hyperthermia, a photothermal most cancers remedy that leverages Sona’s biocompatible gold nanorods, that are gold-shaped, non-toxic nanoparticles product of gold.
“We’re standing on the shoulders of that analysis to say, ‘Look, that is unimaginable data. How can we now deliver it collectively and operationalize it for a remedy that can do good and that can actually create an enhancement over what’s at the moment finished,” Regan stated.
Watch the complete interview with David Regan, CEO of Sona Nanotech, above.
Disclaimer: This interview is sponsored by Sona Nanotech (CSE:SONA,OTCQB:SNANF). This interview offers data which was sourced by the Investing Information Community (INN) and authorized by Sona Nanotech with a purpose to assist traders be taught extra concerning the firm. Sona Nanotech is a shopper of INN. The corporate’s marketing campaign charges pay for INN to create and replace this interview.
INN doesn’t present funding recommendation and the knowledge on this profile shouldn’t be thought of a advice to purchase or promote any safety. INN doesn’t endorse or advocate the enterprise, merchandise, providers or securities of any firm profiled.
The data contained right here is for data functions solely and isn’t to be construed as a suggestion or solicitation for the sale or buy of securities. Readers ought to conduct their very own analysis for all data publicly out there regarding the firm. Prior to creating any funding determination, it is suggested that readers seek the advice of instantly with Sona Nanotech and search recommendation from a certified funding advisor.
This interview could include forward-looking statements together with however not restricted to feedback concerning the timing and content material of upcoming work applications, receipt of property titles, and many others. Ahead-looking statements tackle future occasions and situations and due to this fact contain inherent dangers and uncertainties. Precise outcomes could differ materially from these at the moment anticipated in such statements. The issuer depends upon litigation safety for forward-looking statements. Investing in corporations comes with uncertainties as market values can fluctuate.